Expansion of analytical capacities by 3P Biopharmaceuticals

Expansion of analytical capacities by 3P Biopharmaceuticals

3P Biopharmaceuticals has recently increased its analytical capacities and capabilities.

The 3P Analytical Development Area is one of the company’s core competences and is crucial to the state-of-the-art technologies as well as services it provides to the clients.

Expansion of analytical capacities by 3P Biopharmaceuticals

The development of analytical methods is an essential activity in any process development and manufacturing of biologics.

Analytical Development area is enjoying larger, more comfortable rooms. This expansion allowed 3P to optimise the daily activities as well as create the potential for further improvements.

In addition to area expansion 3P has made a great economic investment in state-of-the-art equipment and technology that increases its capabilities to support the Clients in various needs of analytical methods development, process development and manufacturing of biopharmaceuticals. 3P also offers analytical solutions in the late stages of the biopharmaceuticals´ development – process characterisation, which ensures successful entrance to the market.

Our dedicated team of specialists will be happy to discuss any of your analytical needs. Contact us on +34 948 346 480 or email withinus@3pbio.com

Related Content

3P Biopharmaceuticals celebrates its 15th anniversary with Juan Carlos Unzué.

3P Biopharmaceuticals, a Navarre company founded in 2007, met with 370 employees in an exciting and joyful event looking back over its 15 years of trajectory.
Read more

3P Biopharmaceuticals and Biosergen complete together the manufacture of biomass for the Mucormycosis “Black Fungus” clinical phase II trial.

3P Biopharmaceuticals has completed the manufacture of BSG005 biomass planned for its client Biosergen. The client also recently announced Phase II clinical trial of BSG005 against Mucormycosis, otherwise known as the Black Fungus.
Read more

Regional Minister Irujo presents the Navarra Health Cluster

This morning, the Regional Minister for Economic and Business Development, Mikel Irujo, presented the Navarra Health Cluster, seeking to position the region as a European benchmark in personalized medicine, one of the priorities of the S4 Smart Specialisation Strategy. The initiative, which stems from the sector's demand and is led by a driving group, is now open to other companies and entities interested in participating.
Read more

Get in touch

Let’s discuss your biologics journey.

Discover more about our people, our passion, and how we can work together to improve lives.